177 related articles for article (PubMed ID: 23725709)
1. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?
Senan S; Paul MA; Lagerwaard FJ
Lancet Oncol; 2013 Jun; 14(7):e270-4. PubMed ID: 23725709
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
4. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
Pennathur A; Abbas G; Christie N; Landreneau R; Luketich JD
Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.
Griffioen GH; Lagerwaard FJ; Haasbeek CJ; Smit EF; Slotman BJ; Senan S
Radiother Oncol; 2013 Jun; 107(3):403-8. PubMed ID: 23746675
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist.
Huang K; Palma DA;
J Thorac Oncol; 2015 Mar; 10(3):412-9. PubMed ID: 25695219
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
[TBL] [Abstract][Full Text] [Related]
9. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of stereotactic ablative radiotherapy in patients with previous pneumonectomy.
Giaj Levra N; Filippi AR; Guarneri A; Badellino S; Mantovani C; Ruffini E; Ricardi U
Tumori; 2015; 101(2):148-53. PubMed ID: 25768317
[TBL] [Abstract][Full Text] [Related]
11. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
12. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
[TBL] [Abstract][Full Text] [Related]
14. Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment.
Hopmans W; Zwaan L; Senan S; van der Wulp I; Damman OC; Hartemink KJ; Smit EF; Timmermans DR
Radiother Oncol; 2015 Jun; 115(3):361-6. PubMed ID: 26036595
[TBL] [Abstract][Full Text] [Related]
15. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer.
Huang K; Senthi S; Palma DA; Spoelstra FO; Warner A; Slotman BJ; Senan S
Radiother Oncol; 2013 Oct; 109(1):51-7. PubMed ID: 23953413
[TBL] [Abstract][Full Text] [Related]
16. The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
Weder W; Moghanaki D; Stiles B; Siva S; Rocco G
Eur J Cardiothorac Surg; 2018 Feb; 53(2):295-305. PubMed ID: 29309549
[TBL] [Abstract][Full Text] [Related]
17. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.
Haasbeek CJ; Lagerwaard FJ; de Jaeger K; Slotman BJ; Senan S
Cancer; 2009 Feb; 115(3):587-94. PubMed ID: 19130457
[TBL] [Abstract][Full Text] [Related]
20. Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy.
Moore W; Chaya Y; Chaudhry A; Depasquale B; Glass S; Lee S; Shin J; Mikhail G; Bhattacharji P; Kim B; Bilfinger T
J Comput Assist Tomogr; 2015; 39(5):804-9. PubMed ID: 25974720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
